AXGN

Companies
NASDAQ
Axogen Inc.
Health Care
Price Chart
Overview

About AXGN

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Market Cap
$304.6M
Volume
10.2M
Avg. Volume
6.2M
P/E Ratio
38.16129
Dividend Yield
0.00%
Employees
423.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Medical Devices
Risk & Correlation Analysis
Market Correlation
0.56
Low Correlation
Volatility
High (0.66)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for AXGN.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, AXGN shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$304.6M
Volume10.2M
P/E Ratio38.16
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 8, 2025
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how AXGN fits into your investment strategy and portfolio diversification.

Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025